Cathepsin S inhibition changes regulatory T‐cell activity in regulating bladder cancer and immune cell proliferation and apoptosis

[1]  P. Libby,et al.  This information is current as Mice lprFas Lupus Erythematosus-like Manifestations in Cathepsin K Deficiency Ameliorates Systemic , 2017 .

[2]  M. Abdelsalam,et al.  Epstein–Barr virus and regulatory T cells in Egyptian paediatric patients with acute B lymphoblastic leukaemia , 2016, Journal of Clinical Pathology.

[3]  B. Rocha,et al.  Depletion of Regulatory T Cells Induces High Numbers of Dendritic Cells and Unmasks a Subset of Anti-Tumour CD8+CD11c+ PD-1lo Effector T Cells , 2016, PloS one.

[4]  A. Tedgui,et al.  Regulatory T-Cell Plasticity: Another Layer of Complexity in Atherosclerosis. , 2016, Circulation research.

[5]  M. Hattori,et al.  Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers , 2016, Nature Medicine.

[6]  Shuai Li,et al.  PD-L1 Expression Is Associated with Tumor FOXP3+ Regulatory T-Cell Infiltration of Breast Cancer and Poor Prognosis of Patient , 2016, Journal of Cancer.

[7]  B. Undar,et al.  Ex vivo evaluation of the effect of regulatory T cells on the anti-tumor activity of bortezomib in multiple myeloma. , 2016, Experimental hematology.

[8]  C. Zhang,et al.  Regulatory T cells in cardiovascular diseases , 2016, Nature Reviews Cardiology.

[9]  F. Grillo,et al.  Residual tumor micro-foci and overwhelming regulatory T lymphocyte infiltration are the causes of bladder cancer recurrence , 2016, Oncotarget.

[10]  Yan Cai,et al.  Ovarian carcinoma-infiltrating regulatory T cells were more potent suppressors of CD8+ T cell inflammation than their peripheral counterparts, a function dependent on TIM3 expression , 2016, Tumor Biology.

[11]  J. M. Suh,et al.  Depletion of Fat Tregs Prevents Age-Associated Insulin Resistance , 2015, Nature.

[12]  Bin Shang,et al.  Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis , 2015, Scientific Reports.

[13]  M. Farrar,et al.  Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells , 2015, The Journal of Immunology.

[14]  Nikhil S. Joshi,et al.  Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses. , 2015, Immunity.

[15]  Claudia C. Preston,et al.  Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer , 2015, Cancer Immunology, Immunotherapy.

[16]  J. Wan,et al.  Functional role of regulatory T cells in B cell lymphoma and related mechanisms. , 2015, International journal of clinical and experimental pathology.

[17]  P. Libby,et al.  Regulatory T cells in human and angiotensin II-induced mouse abdominal aortic aneurysms. , 2015, Cardiovascular research.

[18]  L. Hansson,et al.  CD4+ regulatory T cells in gastric cancer mucosa are proliferating and express high levels of IL-10 but little TGF-β , 2015, Gastric Cancer.

[19]  D. DeBrota,et al.  Pharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in healthy subjects. , 2014, British journal of clinical pharmacology.

[20]  R. deLeeuw,et al.  The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature , 2012, Clinical Cancer Research.

[21]  K. Okumura,et al.  Role for Cysteine Protease Cathepsins in Heart Disease: Focus on Biology and Mechanisms With Clinical Implication , 2012, Circulation.

[22]  R. deLeeuw,et al.  The Prognostic Value of FoxP 3 þ Tumor-In fi ltrating Lymphocytes in Cancer : A Critical Review of the Literature , 2012 .

[23]  K. Okumura,et al.  Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications. , 2011, Hypertension.

[24]  W. Patsch,et al.  Potential Role of Regulatory T Cells in Reversing Obesity-Linked Insulin Resistance and Diabetic Nephropathy , 2011, Diabetes.

[25]  B. Ristau,et al.  Prognostic implications of lymph node involvement in bladder cancer: are we understaging using current methods? , 2011, BJU international.

[26]  J. Wright,et al.  Urinary bladder masses: techniques, imaging spectrum, and staging. , 2011, Journal of computer assisted tomography.

[27]  D. Böckler,et al.  Deficient CD4+CD25+ T Regulatory Cell Function in Patients With Abdominal Aortic Aneurysms , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[28]  G. Li,et al.  Involvement of T helper type 17 and regulatory T cell activity in tumour immunology of bladder carcinoma , 2010, Clinical and experimental immunology.

[29]  L. Terracciano,et al.  High frequency of tumor‐infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair‐proficient colorectal cancer patients , 2010, International journal of cancer.

[30]  D. Böckler,et al.  Deficient CD 4 CD 25 T Regulatory Cell Function in Patients With Abdominal Aortic Aneurysms , 2010 .

[31]  D. Sargent,et al.  Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma. , 2009, Gastroenterology.

[32]  Christophe Benoist,et al.  Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters , 2009, Nature Medicine.

[33]  N. Zeps,et al.  Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  M. Gur,et al.  CD4+ CD25+ regulatory T-cells in acute coronary syndromes. , 2007, European heart journal.

[35]  T. Tötterman,et al.  Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokines. , 2007, The Journal of urology.

[36]  G. Dranoff,et al.  Cathepsin S required for normal MHC class II peptide loading and germinal center development. , 1999, Immunity.

[37]  I. Summerhayes,et al.  Effects of donor age on neoplastic transformation of adult mouse bladder epithelium in vitro. , 1979, Journal of the National Cancer Institute.